Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Fukuoka

Showing results (1-10 of 415) with videos related to

Pageof 42
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 1, 1993
["State of the art" of chemotherapy for lung cancer]M Fukuoka
Oncology (Williston Park, N.Y.)|April 17, 2001
State of the art of non-small-cell lung cancer in the new millenniumM Fukuoka
Oncology (Williston Park, N.Y.)|August 11, 2001
Role of topoisomerase I inhibitors in small-cell lung cancerM Fukuoka
Chemical & Pharmaceutical Bulletin|September 1, 1982
Chemical and toxicological studies on bracken fern, Pteridium aquilinum var. latiusculum. VI. Isolation of 5-O-caffeoylshikimic acid as an antithiamine factorM Fukuoka
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 29, 2000
[Current perspectives of new agents in lung cancer]M Fukuoka
Oncology (Williston Park, N.Y.)|February 28, 2001
Current status of irinotecan in lung cancerM Fukuoka
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 1, 1996
[Current status and problems in clinical trial for new anticancer drug in Japan]M Fukuoka
Nihon Geka Gakkai Zasshi|January 1, 1997
[Therapeutic strategy for small cell lung cancer]M Fukuoka
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|January 10, 1997
[Diagnosis and treatment of lung cancer--current trends]M Fukuoka
Josanpu Zasshi = the Japanese Journal for Midwife|February 1, 1983
[Visits to St. Mary's Hospital, England, and Hadassah hospital, Israel]M Fukuoka
Pageof 42

Showing results (1-10 of 415) with videos related to

Sort By:
Pageof 42
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 1, 1993
["State of the art" of chemotherapy for lung cancer]M Fukuoka
Oncology (Williston Park, N.Y.)|April 17, 2001
State of the art of non-small-cell lung cancer in the new millenniumM Fukuoka
Oncology (Williston Park, N.Y.)|August 11, 2001
Role of topoisomerase I inhibitors in small-cell lung cancerM Fukuoka
Chemical & Pharmaceutical Bulletin|September 1, 1982
Chemical and toxicological studies on bracken fern, Pteridium aquilinum var. latiusculum. VI. Isolation of 5-O-caffeoylshikimic acid as an antithiamine factorM Fukuoka
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 29, 2000
[Current perspectives of new agents in lung cancer]M Fukuoka
Oncology (Williston Park, N.Y.)|February 28, 2001
Current status of irinotecan in lung cancerM Fukuoka
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 1, 1996
[Current status and problems in clinical trial for new anticancer drug in Japan]M Fukuoka
Nihon Geka Gakkai Zasshi|January 1, 1997
[Therapeutic strategy for small cell lung cancer]M Fukuoka
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|January 10, 1997
[Diagnosis and treatment of lung cancer--current trends]M Fukuoka
Josanpu Zasshi = the Japanese Journal for Midwife|February 1, 1983
[Visits to St. Mary's Hospital, England, and Hadassah hospital, Israel]M Fukuoka
Pageof 42